Novavax Inc

NVV1.HM·Hamburg
Compare
9.41+0.37 (+4.09%)today
As of Nov 5, 8:30 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close9.04
Open9.41
Day range—
52-week range5.4111.60
Off day high0.00%
Off 52-week high−18.88%
Volume0.00
Avg. volume (3M)149
Market cap—
EPS (TTM)—
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding—
Short interest—
Earnings dateNov 5, 2026
Analyst target—
Profit margin—

Against its peers

Compare in full ›
NVV1.HM 194700.KQ 300142.SZ PCVX BAVA.CO 6547.TWO
Market cap — 157.84B 18.70B 10.34B 18.64B 15.63B
P/E (TTM) — — 1,169.0 — 12.8 —
Forward P/E — — 26.0 -9.2 22.2 32.6
Price/book — — 2.7 3.2 1.4 4.4
Dividend yield — 4.52% 1.35% — — —
1-year change +30.91% −48.90% −6.23% +57.47% +31.98% +42.31%
Today +4.09% +0.45% +2.19% +8.01% +1.22% −2.16%

The closest companies by business. Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Novavax's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
NOVAREX Co.,Ltd.194700.KQ · Packaged Foods 157.84B 8,890.00 +0.45%
Walvax Biotechnology Co., Ltd.300142.SZ · Drug Manufacturers - Specialty & Generic 18.70B 11.69 +2.19%
Vaxcyte, Inc.PCVX · Biotechnology 10.34B 65.68 +8.01%
Bavarian Nordic A/SBAVA.CO · Biotechnology 18.64B 249.80 +1.22%
Medigen Vaccine Biologics Corporation6547.TWO · Biotechnology 15.63B 47.55 −2.16%
Novartis AG0QLR.IL · Drug Manufacturers - General 306.88B 133.84 +0.91%
GlaxoSmithKline Pharmaceuticals LimitedGLAXO.BO · Drug Manufacturers - General 423.63B 2,500.70 −1.26%
SanofiSNY · Drug Manufacturers - General 113.74B 47.47 +4.72%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All NVV1.HM news ›
AOL.com··2 outletsPositive

Novavax Earns $125 Million Milestone as Sanofi Launches Phase 3 Influenza-COVID-19 Combination Vaccine Trial in Europe

Novavax (Nasdaq: NVAX) has earned a $125 million milestone payment with the initiation (fifth patient dosed) of Sanofi's Phase 3 influenza-COVID-19 combination vaccine trial utilizing Novavax's ... The global flu and COVID-19 markets have…

NVAXPFEMRNASNY
More from 1 other outlet

From the 4Search news index, newest first.

In the news

37mentions in 30 days
37with it in the headline
Positivesentiment

Mentioned with

Novavax, Inc24Sanofi23Novartis22Novavax, Inc.22Moderna19Pfizer19Novo Nordisk17Eli Lilly12

People in the coverage

Moderna32Mitch Edgeman21Keytruda16Kim Johansen10Donald Trump9Kamal Choudhury8

Themes

Healthcare19Moderna15Health14Mrna13Nvax11Biotechnology9Cancer Vaccine8Melanoma8

Most coverage from

  1. themarketsdaily.com6
  2. 247wallst.com5
  3. aol.com2
  4. coincentral.com2
  5. coinmarketcap.com2

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 37 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance